Is Universal HBV Vaccination of Healthcare Workers a Relevant Strategy in Developing Endemic Countries? The Case of a University Hospital in Niger

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Pellissier, Gérard ^a   Yazdanpanah, Yazdan ^b,c   Adehossi, Eric ^d   Tosini, William ^a   Madougou, Boubacar ^d,e   Ibrahima, Kaza ^d   Lolom, Isabelle ^a,b   Legac, Sylvie ^a,b   Rouveix, Elisabeth ^a,e,f   Champenois, Karen ^c   Rabaud, Christian ^a,g   Bouvet, Elisabeth ^a,b  

^a Groupe d'Etude sur le Risque d'Exposition des Soignants aux agents infectieux (GERES)   (France)

^b BICHAT HOSPITAL   (France)

^c INSERM   (France)

^d HÔPITAL NATIONAL DE NIAMEY   (Niger)

^e GIP ESTHER ^*

^f HÔPITAL AMBROISE PARÉ   (France)

^g UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DEVELOPING COUNTRY; ENDEMIC DISEASE; FEMALE; HEALTH CARE PERSONNEL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NIGER; PREVALENCE; PRIMARY PREVENTION; UNIVERSITY HOSPITAL; VACCINATION; VIRUS LOAD;

ADULT; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; ENDEMIC DISEASES; FEMALE; HEPATITIS B VACCINES; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; NIGER; PERSONNEL, HOSPITAL;

HEPATITIS B VIRUS;

EID: 84866130623     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044442     Document Type: Article

References (38)

1. World Health Organization (2008) Hepatitis B. World Health Organization Fact Sheet 204 (Revised August 2008). Available: http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed: 2012 Jan 31.
2. Mahoney FJ, (1999) Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 12(2): 351-366.
3. Zanetti AR, Van Damme P, Shouval D, (2008) The global impact of vaccination against hepatitis B: a historical overview. Vaccine 26: 6266-6273.
4. Foruin M, Chotard J, Jack AD, Maine NP, Mendy M, et al. (1993) Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. Lancet 341: 1129-1131.
5. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, et al. (2005) A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34: 1329-1339.
6. Beltrami EM, Williams IT, Shapiro CN, Chamberland ME, (2000) Risk and management of blood-borne infections in healthcare workers. Clin Microbiol Rev 13(3): 385-407.
7. Tarantola A, Abiteboul D, Rachline A, (2006) Infection risks following accidental exposure to blood or body fluids in health care workers: A review of pathogens transmitted in published cases. Am J Infect Control 34: 367-375.
8. Gerberding JL, (1995) Management of occupational exposures to blood-borne viruses. N Engl J Med 332(7): 444-451.
9. De Schryver A, Claesen B, Meheus A, Van Sprundel M, François G, (2011) European survey of hepatitis B vaccination policies for healthcare workers. Eur J Public Health 21(3): 338-343.
10. Centers for Disease Control and Prevention (1997) Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 46(No. RR-18): 1-44.
11. Bonanni P, Bonaccorsi G, (2001) Vaccination against hepatitis B in health care workers. Vaccine 19: 2389-2394.
12. Ziraba AK, Bwogi J, Namale A, Wainaina CW, Mayanja-Kizza H, (2010) Sero-prevalence and risk factors for hepatitis B virus infection among health care workers in a tertiary hospital in Uganda. BMC Infect Dis 10: 191-202.
13. Kesieme EB, Uwakwe K, Irekpita E, Dongo A, Bwala KJ, et al. (2011) Knowledge of hepatitis B vaccine among operating room personnel in Nigeria and their vaccination status. Hepat Res Treat. Article ID 157089,5 pages. Doi:10.1155/2011/157089.
14. Suckling RM, Taegtmeyer M, Nguku PM, Al-Abri SS, Kibaru J, et al. (2006) Susceptibility of healthcare workers in Kenya to hepatitis B: new strategies for facilitating vaccination uptake. J Hosp Infect 64: 271-277.
15. Tarantola A, Koumare A, Rachline A, Sow PS, Diallo MB, et al. (2005) A descriptive, retrospective study of 567 accidental blood exposures in healthcare workers in three West African countries. J Hosp Infect 60: 276-282.
16. Prüss-Üstün A, Rapiti E, Hutin Y, (2005) Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med 48: 482-490.
17. Ngatu NR, Phillips EK, Wembonyama OS, Hirota R, Kaunge NJ, et al. (2012) Pratice of universal precautions and risk of occupational blood-borne viral infection among Congolese health care workers. Am J Infect Control 40: 68-70.
18. Philipps EK, Owusu-Ofori A, Jagger J, (2007) Bloodborne pathogen exposure risk among surgeons in Sub-Saharan Africa. Infect Control Hosp Epidemiol 28(12): 1334-1336.
19. Sagoe-Moses C, Pearson RD, Perry J, Jagger J, (2001) Risks to health care workers in developing countries. N Engl J Med 345(7): 538-541.
20. Burnett RJ, François G, Mphahlele MJ, Mureithi JG, Africa PN, et al. (2011) Hepatitis B vaccination coverage in healthcare workers in Gauteng Province, South Africa. Vaccine 29: 4293-4297.
21. Olubuyide IO, Ola SO, Dosumu OO, Arotiba JT, Olaleye OA, et al. (1997) Hepatitis B and C in doctors and dentists in Nigeria. Q J Med 90: 417-422.
22. Mast EE, Alter MJ, Margolis HS, (1999) Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 17: 1730-1733.
23. Hou J, Liu Z, Gu F, (2005) Epidemiology and prevention of Hepatitis B virus infection. Int J Med Sci 2(1): 50-57.
24. Romieu I, Sow I, Lu S, Laroque G, Prince-David M, et al. (1989) Prevalence of hepatitis B markers among hospital workers in Senegal. J Med Virol 27(4): 282-287.
25. Wasley A, Kruszon-Moran D, Kuhnert W, Simard EP, Finelli L, et al. (2010) The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 202: 192-201.
26. Braka F, Nanyunja M, Makumbi I, Mbabazi W, Kasasa S, et al. (2006) Hepatitis B infection among health workers in Uganda: Evidence of the need for health worker protection. Vaccine 24: 6930-6937.
27. Belo AC, (2000) Prevalence of hepatitis B virus markers in surgeons in Lagos, Nigeria. East Afr Med J 77(5): 283-285.
28. Soubiran G, Le Bras M, Marini P, et al. (1987) High HbsAg and anti-delta carrier rate among asymptomatic Africans living on the campus of the University of Niamey, Niger. Trans R Soc Trop Med Hyg 81(6): 998-1000.
29. Mamadou S, Idé M, Gagara H, et al. (2009) Hepatitis B and C seroprevalence among people living with HIV/AIDS in Niger. Journal de la Société de Biologie Clinique 013: 42-44. [French].
30. Mamadou S, Rabo S, Ali Maazou AR, et al. (2010) HIV infection, hepatitis B and C seroprevalence among blood donors of Niamey in 2007. Annales de l'Université Abdou Moumouni 11(Tome A): 28-31. [French].
31. Mamadou S, Ide M, Ali Maazou AR, Aoula B, Labo S, Bozari M, (2012) HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa. HIV/AIDS - Research and Palliative Care 4: 1-4.
32. Soubiran G, Sekou H (1984) Serological study of hepatitis B in Niger. Ann. Virol (Inst. Pasteur) 135 E: 213-218.
33. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP, (2006) Hepatitis B infection: Epidemiology and vaccination. Epidemiol Rev 28: 112-125.
34. Kane M, (1995) Global programme for control of hepatitis B infection. Vaccine 13(1): S47-S49.
35. Beutels P, (2001) Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000). Health Econ 10: 751-774.
36. Barrigar DL, Flagel DC, Upshur EG, (2001) Hepatitis B virus infected physicians and disclosure of transmission risks to patients: A critical analysis. BMC Medical Ethics 2: 4.
37. Wiersma ST, McMahon B, Pawlotsky JM, Thio CL, Thursz M, et al. (2011) Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus. Liver Int 6: 755-761.
38. Kim SR, Yang J, Kudo M, Hino O, (2011) Recent advances in the management of chronic hepatitis B. Hepat Mon. 11(8): 601-611.